Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_assertion type Assertion NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_head.
- NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_assertion description "[In adulthood, X-ALD most commonly manifests as a gradually progressive myelopathy (adrenomyeloneuropathy; AMN) without any curative or disease modifying treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_provenance.
- NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_assertion evidence source_evidence_literature NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_provenance.
- NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_assertion SIO_000772 25499606 NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_provenance.
- NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_assertion wasDerivedFrom befree-2016 NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_provenance.
- NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_assertion wasGeneratedBy ECO_0000203 NP1247213.RA2vdgsCQRBvlLvEtMg0S_e4m2xUVD5UsBxfrvv6iVB5I130_provenance.